Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jerome J. Schentag · SciRah

Researcher profile · Semantic Scholar

Jerome J. Schentag

University at Buffalo
CPL Associates LLC
TheraSyn

Share profile

Jerome J. Schentag — researcher profile on SciRah

h-index: 75
Works: 358
Citations: 20K

Most-cited papers

Challenges and Potential Solutions – Individualised Antibiotic Dosing at the Bedside for Critically Ill Patients: a structured review
J. Roberts, M. Abdul-Aziz, J. Lipman, J. Mouton +10 more
2014Lancet. Infectious Diseases (Print)874 citations Open access
Semantic Scholar
Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections
P. Moise-Broder, A. Forrest, M. Birmingham, Jerome J. Schentag
2004Clinical Pharmacokinetics764 citations Open access
Semantic Scholar
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
P. Mckinnon, J. Paladino, Jerome J. Schentag
2008International Journal of Antimicrobial Agents453 citations
Semantic Scholar
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.
M. Birmingham, C. Rayner, A. Meagher, S. Flavin +2 more
2003Clinical Infectious Diseases424 citations Open access
Semantic Scholar
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
P. Moise-Broder, G. Sakoulas, G. Eliopoulos, Jerome J. Schentag +2 more
2004Clinical Infectious Diseases355 citations
Semantic Scholar
The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database.
G. Noskin, R. Rubin, Jerome J. Schentag, J. Kluytmans +4 more
2005Archives of Internal Medicine336 citations
Semantic Scholar
Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme
C. Rayner, A. Forrest, A. Meagher, M. Birmingham +1 more
2003Clinical Pharmacokinetics301 citations
Semantic Scholar
Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid
S. Kiem, Jerome J. Schentag
2007Antimicrobial Agents and Chemotherapy286 citations Open access
Semantic Scholar
Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia
P. Moise, G. Sakoulas, A. Forrest, Jerome J. Schentag
2007Antimicrobial Agents and Chemotherapy241 citations Open access
Semantic Scholar
Clinical experience with linezolid for the treatment of nocardia infection.
E. Moylett, S. Pacheco, B. Brown-Elliott, T. R. Perry +8 more
2003Clinical Infectious Diseases231 citations
Semantic Scholar
National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003).
G. Noskin, R. Rubin, Jerome J. Schentag, J. Kluytmans +5 more
2007Clinical Infectious Diseases211 citations Open access
Semantic Scholar
Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program
A. Meagher, A. Forrest, C. Rayner, M. Birmingham +1 more
2003Antimicrobial Agents and Chemotherapy164 citations Open access
Semantic Scholar
What have we learned from pharmacokinetic and pharmacodynamic theories?
Jerome J. Schentag, K. Gilliland, J. Paladino
2001Clinical Infectious Diseases149 citations Open access
Semantic Scholar
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
R. Wilson, Jerome J. Schentag, P. Ball, L. Mandell
2002Clinical Therapeutics148 citations
Semantic Scholar
Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
Scott V. Monte, J. Caruana, H. Ghanim, Ling-Sia Chang +3 more
2012Surgery144 citations
Semantic Scholar
Linezolid in the Treatment of Osteomyelitis: Results of Compassionate Use Experience
C. Rayner, L. Baddour, M. Birmingham, C. Norden +2 more
2004Infection135 citations
Semantic Scholar
Factors Associated With Postoperative Infection
J. Scott, A. Forrest, S. Feuerstein, P. Fitzpatrick +1 more
2001Infection Control & Hospital Epidemiology111 citations
Semantic Scholar
Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models.
Jerome J. Schentag
2000Clinical Infectious Diseases93 citations
Semantic Scholar
Novel Pharmacokinetic-Pharmacodynamic Model for Prediction of Outcomes with an Extended-Release Formulation of Ciprofloxacin
A. Meagher, A. Forrest, A. Dalhoff, H. Stass +1 more
2004Antimicrobial Agents and Chemotherapy85 citations Open access
Semantic Scholar
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.
P. Moise, A. Forrest, M. Birmingham, Jerome J. Schentag
2002Journal of Antimicrobial Chemotherapy85 citations
Semantic Scholar
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
A. Brink, G. Richards, V. Schillack, S. Kiem +1 more
2009International Journal of Antimicrobial Agents80 citations
Semantic Scholar
Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates Part 2: Human Trials
Jerome J. Schentag, A. Meagher, A. Forrest
2003The Annals of Pharmacotherapy79 citations
Semantic Scholar
Sex Differences in Nevirapine Rash
Xuan Zhong, Blondeau, Jm, X. Zhao +13 more
201077 citations
Semantic Scholar
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia.
P. Smith, M. Birmingham, G. Noskin, A. Meagher +3 more
2003Annals of Oncology77 citations Open access
Semantic Scholar
Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit
Jerome J. Schentag
2001Critical Care Medicine75 citations
Semantic Scholar
Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates
Jerome J. Schentag, A. Meagher, A. Forrest
2003The Annals of Pharmacotherapy74 citations
Semantic Scholar
Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients.
Patrick F. Smith, C. Ballow, B. M. Booker, A. Forrest +1 more
2001Clinical Therapeutics73 citations
Semantic Scholar
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
I. Puzanov, Poornima Subramanian, Y. Yatsynovich, D. Jacobs +18 more
2021Journal for ImmunoTherapy of Cancer71 citations Open access
Semantic Scholar
NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
Xiao-fei Zhou, Linping Zhang, E. Tseng, Elizabeth A Scott-Ramsay +3 more
2005Drug Metabolism And Disposition69 citations
Semantic Scholar
Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic Parameters
K. Pickerill, J. Paladino, Jerome J. Schentag
2000Pharmacotherapy67 citations
Semantic Scholar
Economic Consequences of Antimicrobial Resistance
J. Paladino, Jenna L Sunderlin, C. Price, Jerome J. Schentag
2002Surgical Infections59 citations
Semantic Scholar
Clinical Use of Ceftriaxone
T. R. Perry, Jerome J. Schentag
2001Clinical Pharmacokinetics53 citations
Semantic Scholar
Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects
Jerome J. Schentag, G. Hill, Tom Chu, C. Rayner
2007Journal of clinical pharmacology45 citations
Semantic Scholar
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals.
S. Bhavnani, W. Callen, A. Forrest, K. Gilliland +3 more
2003American Journal of Health-System Pharmacy41 citations
Semantic Scholar
Pharmacokinetics and metabolism of moxifloxacin.
P. Moise, M. Birmingham, Jerome J. Schentag
2000Drugs of Today41 citations
Semantic Scholar
Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization.
A. Luzier, A. Forrest, S. Feuerstein, Jerome J. Schentag +1 more
2000American Journal of Cardiology38 citations
Semantic Scholar
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
J. Paladino, D. Jacobs, R. Shields, Jerusha Taylor +5 more
2014International Journal of Antimicrobial Agents36 citations
Semantic Scholar
Budget Impact Analysis of Rapid Screening for Staphylococcus aureus Colonization Among Patients Undergoing Elective Surgery in US Hospitals
G. Noskin, R. Rubin, Jerome J. Schentag, J. Kluytmans +5 more
2008Infection Control & Hospital Epidemiology33 citations
Semantic Scholar
Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
S. Kiem, Jerome J. Schentag
2006Seminars in Respiratory and Critical Care Medicine30 citations
Semantic Scholar
A Case Series of Macrolide Treatment Failures in Community Acquired Pneumonia
P. Iannini, J. Paladino, B. Lavin, M. Singer +1 more
2007Journal of chemotherapy29 citations
Semantic Scholar
Interpretation of Epithelial Lining Fluid Concentrations of Antibiotics against Methicillin Resistant Staphylococcus aureus
S. Kiem, Jerome J. Schentag
2014Infection & Chemotherapy28 citations Open access
Semantic Scholar
Once‐Daily Cefepime Versus Ceftriaxone for Nursing Home–Acquired Pneumonia
J. Paladino, D. Eubanks, M. Adelman, Jerome J. Schentag
2007Journal of The American Geriatrics Society27 citations
Semantic Scholar
Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae.
Jerome J. Schentag
2002Journal of chemotherapy27 citations
Semantic Scholar
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Jerome J. Schentag, K. Klugman, V. Yu, M. Adelman +5 more
2007International Journal of Antimicrobial Agents25 citations
Semantic Scholar
Fluoroquinolone pharmacodynamics. Authors' reply
G. Drusano, S. L. Preston, R. Owens, P. Ambrose +3 more
200125 citations
Semantic Scholar
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.
J. Tran, C. Ballow, A. Forrest, J. Hyatt +3 more
2000Journal of Antimicrobial Chemotherapy25 citations Open access
Semantic Scholar
Costs of treating lower respiratory tract infections.
Scott V. Monte, Nicole M. Paolini, Erin M. Slazak, Jerome J. Schentag +1 more
2008American Journal of Managed Care22 citations
Semantic Scholar
Clinical Experience With Linezolid in Conjunction With Wound Coverage Techniques for Skin and Soft-Tissue Infections and Postoperative Osteomyelitis
Kevin W Broder, P. Moise, Raymond O. Schultz, A. Forrest +1 more
2004Annals of Plastic Surgery22 citations
Semantic Scholar
Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
J. Paladino, Jenna L Sunderlin, A. Forrest, Jerome J. Schentag
2003Journal of Antimicrobial Chemotherapy19 citations
Semantic Scholar
Potential Role of Pharmacokinetics, Pharmacodynamics, and Computerized Databases in Controlling Bacterial Resistance
J. Hyatt, Jerome J. Schentag
2000Infection Control & Hospital Epidemiology19 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Forrest×17
Invite
A. Forrest — researcher profile on SciRah
J. Paladino×12
Invite
J. Paladino — researcher profile on SciRah
M. Birmingham×9
Invite
M. Birmingham — researcher profile on SciRah
A. Meagher×8
Invite
A. Meagher — researcher profile on SciRah

×6

Invite

C. Rayner — researcher profile on SciRah

Invite

G. Noskin — researcher profile on SciRah

Invite

S. Kiem — researcher profile on SciRah

Invite

P. Moise — researcher profile on SciRah

Invite

R. Rubin — researcher profile on SciRah

J. Kluytmans×3

Invite

J. Kluytmans — researcher profile on SciRah

Invite

E. Hedblom — researcher profile on SciRah

Invite

M. Smulders — researcher profile on SciRah